Clinical Trial Update: Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of a single-dose MenACYW Conjugate Vaccine in older adults in Turkey and Lebanon has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACYW Conjugate Vaccine (MenACWY conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Healthy Volunteers (Meningococcal Infection) | Phase 3 | Status: COMPLETED | Results posted: 2025-03-17